Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1967 Aug 1;126(2):189–206. doi: 10.1084/jem.126.2.189

A PLASMIN-SPLIT FRAGMENT OF C'3 AS A NEW CHEMOTACTIC FACTOR

Peter A Ward 1
PMCID: PMC2138318  PMID: 4226271

Abstract

When streptokinase and highly purified human plasminogen are added to human serum or to partly purified or highly purified preparations containing the third component of complement (C'3), either rabbit or human, a chemotactic factor is generated. This chemotactic factor is a split product of C'3 and is dialyzable, fast moving electrophoretically, slowly sedimenting in sucrose density gradient ultracentrifugation, and has an approximate molecular weight of 6000. It is calculated that this fragment accounts for approximately 4% of the intact molecule. The C'3 fragment has the following biologic properties: It is chemotactic for rabbit PMN's in vitro, it causes accumulation of PMN's in vivo, and it increases vascular permeability in rat skin. In addition to generating a chemotactic factor, plasmin destroys the complement-associated chemotactic factor that is a trimolecular complex consisting of the fifth (C'5), sixth (C'6), and seventh (C'7) components of complement. This has been shown by a loss of chemotactic activity, as well as a dissociation of the C'5, C'6, C'7 complex and a destruction of C'6 hemolytic activity. The biologic significance of the plasmin-generated chemotactic factor is discussed in relation to other recently discovered biologically active fragments of C'3.

Full Text

The Full Text of this article is available as a PDF (922.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews P. The gel-filtration behaviour of proteins related to their molecular weights over a wide range. Biochem J. 1965 Sep;96(3):595–606. doi: 10.1042/bj0960595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BOYDEN S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med. 1962 Mar 1;115:453–466. doi: 10.1084/jem.115.3.453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. LEPOW I. H., RATNOFF O. D., LEVY L. R. Studies on the activation of a proesterase associated with partially purified first component of human complement. J Exp Med. 1958 Mar 1;107(3):451–474. doi: 10.1084/jem.107.3.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. MARDINEY M. R., Jr, MUELLER-EBERHARD H. J. MOUSE BETA-1C-GLOBULIN: PRODUCTION OF ANTISERUM AND CHARACTERIZATION IN THE COMPLEMENT REACTION. J Immunol. 1965 Jun;94:877–882. [PubMed] [Google Scholar]
  5. NILSSON U. R., MUELLER-EBERHARD H. J. ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT. J Exp Med. 1965 Aug 1;122:277–298. doi: 10.1084/jem.122.2.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. PILLEMER L., RATNOFF O. D., BLUM L., LEPOW I. H. The inactivation of complement and its components by plasmin. J Exp Med. 1953 Apr;97(4):573–589. doi: 10.1084/jem.97.4.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ratnoff O. D. INCREASED VASCULAR PERMEABILITY INDUCED BY HUMAN PLASMIN. J Exp Med. 1965 Oct 31;122(5):905–921. doi: 10.1084/jem.122.5.905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. SPIEGELBERG H. L., MIESCHER P. A., BENACERRAF B. STUDIES ON THE ROLE OF COMPLEMENT IN THE IMMUNE CLEARANCE OF ESCHERICHIA COLI AND RAT ERYTHROCYTES BY THE RETICULOENDOTHELIAL SYSTEM IN MICE. J Immunol. 1963 May;90:751–759. [PubMed] [Google Scholar]
  9. Taylor F. B., Jr, Staprans I. Chromatography, physical characteristics, and disulfide bonds of euglobulin plasminogen. Arch Biochem Biophys. 1966 Apr;114(1):38–49. doi: 10.1016/0003-9861(66)90302-x. [DOI] [PubMed] [Google Scholar]
  10. Taylor F. B., Jr, Ward P. A. Generation of chemotactic activity in rabbit serum by plasminogen-streptokinase mixtures. J Exp Med. 1967 Jul 1;126(1):149–158. doi: 10.1084/jem.126.1.149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. WARD P. A., COCHRANE C. G. BOUND COMPLEMENT AND IMMUNOLOGIC INJURY OF BLOOD VESSELS. J Exp Med. 1965 Feb 1;121:215–234. doi: 10.1084/jem.121.2.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. WARD P. A., COCHRANE C. G., MUELLER-EBERHARD H. J. THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO. J Exp Med. 1965 Aug 1;122:327–346. doi: 10.1084/jem.122.2.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ward P. A., Cochrane C. G., Muller-Eberhard H. J. Further studies on the chemotactic factor of complement and its formation in vivo. Immunology. 1966 Aug;11(2):141–153. [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES